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Highlights: 
 Rosemary extracts show cytotoxic effects in cancer cell models but their active 
compounds are yet to be discovered 
 Bioguided fractionation of rosemary extract was achieved by preparative HPLC 
& fractions characterized by HPLC-ESI-QTOF-MS 
 Carnosic acid, carnosol, 12-methoxycarnosic acid, taxodione, hinokione & 
betulinic acid are the most active compounds 
 Comparative antiproliferative study on the fractions & the whole extract 
revealed potential synergistic effects 
 The antiproliferative or cytotoxic mechanism deserves further attention 
 
ABSTRACT 
Rosemary extracts have exhibited potential cytostatic or cytotoxic 
effects in several cancer cell models but their bioactive compounds 
are yet to be discovered. In this work, the anticancer activity of a 
rosemary-leaf extract and its fractions were assayed to identify the 
phenolic compounds responsible for their antiproliferative/cytotoxic 
effects on a panel of human colon cancer cell lines. Bioguided 
fractionation of the rosemary-leaf extract was achieved by semi-
preparative chromatography. The rosemary extract and the 
compounds in the fractions were characterized and quantified by 
HPLC-ESI-QTOF-MS. Cellular viability in the presence of these 
fractions and the whole extract was determined after 24 or 48 h 
incubations by using a MTT assay. Fractions containing diterpenes or 
triterpenes were the most active but not as much as the whole extract. 
In conclusion, carnosic acid, carnosol, 12-methoxycarnosic acid, 
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taxodione, hinokione and betulinic acid were the putative candidates 
that contributed to the observed antiproliferative activity of rosemary 
in human colon cancer cells. Whether the effects of the extract and 
fractions is only cytostatic or cytotoxic need to be elucidated. 
Nevertheless, the comparative antiproliferative study on the fractions 
and whole extract revealed potential synergistic effects between 
several components in the extract that may deserve further 
attention. 
 
Keywords: antiproliferative activity, cytotoxicity, colon cancer, HPLC-ESI-QTOF-MS, 
rosemary, terpenoids.  
 
 
 
INTRODUCTION 
At present, cancer is a major health problem in many developed countries and a leading 
cause of death worldwide, accounting for 8.2 million deaths in 2012 (World Health 
Organization (WHO), 2014). Colorectal cancer is the fourth most common cause of 
death from cancer, causing approximately 700.000 deaths per year. The risk of 
developing this particular malignancy increases with age and some environmental 
factors, with diet being one of the most closely related factors. An inverse relation 
between high consumption of fruit and vegetables and the colon cancer incidence in a 
population has been reported, and therefore proper nutrition seems to play an important 
role in colorectal cancer prevention (Franceschi et al., 1998; Pan et al., 2011; Pauwels, 
2011). 
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Plants and herbs are a source of compounds with potential anticancer activity that are 
able to prevent, reverse and/or inhibit carcinogenesis at different stages. Among these 
compounds, polyphenols have attracted interest because of the pleiotropic properties 
that target different inflammatory, redox-sensitive and energy-sensing metabolic 
pathways by modulating the activity of different transcription factors (Barrajón-Catalán 
et al., 2014; Menendez et al., 2013), which is consistent with the multifactorial character 
of cancer. The potential use of several individual polyphenols such as quercetin, ellagic 
acid or chlorogenic acid, or different vegetable matrices, e.g., green tea or olive oil, to 
treat colorectal cancer has been reported (Hosokawa et al., 1990; Pahlke et al., 2006; 
Shan et al., 2009; Xavier et al., 2009; Kim et al., 2010).  
Rosemary (Rosmarinus officinalis L.) is a shrub from the family Labiatae (Lamiaceae) 
that is mostly distributed throughout the Mediterranean area. Diterpenes such as 
carnosic acid (CA) and carnosol (CAR) are abundant in rosemary leaves, in addition to 
the caffeoyl derivative rosmarinic acid. A wide variety of biological activities have been 
attributed to this plant, namely hepatoprotective (Sotelo-Félix et al., 2002), 
antimicrobial (Del Campo et al., 2000; Bozin et al., 2007), antithrombotic (Yamamoto 
et al., 2005), diuretic (Haloui et al., 2000), antidiabetic (Bakirel et al., 2008), anti-
inflammatory (Altinier et al., 2007), antioxidant (Pérez-Fons et al., 2010) and anti-
cancer (Lo et al., 2002; Dörrie et al., 2001; Huang et al., 2005; Visanji et al., 2006). 
Accordingly, the inhibitory effects of rosemary extracts and their isolated components 
on the growth of breast, liver, prostate, lung and leukemia cancer cells has been reported 
(Yesil-Celiktas et al., 2010; Johnson, 2011). By using transcriptomic and metabolomic 
analyses, we recently showed that CA and CAR exert antiproliferative/cytotoxic effects 
on colon cancer cells by activating nuclear receptor factor 2 (NRF2)-dependent 
pathways and ROS metabolism, which is accompanied by elevated levels of glutathione 
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and decreased levels of N-acetyl putrescine (Valdés et al., 2014). This finding is 
consistent with the activation of genes related to the antioxidant phase II enzymes 
observed in a transcriptomic analysis on the effects of a diterpene-enriched rosemary 
extract on colon cancer cells (Valdés et al., 2013). Nevertheless, the whole extract 
seems to exert additional changes on the expression of genes related to cell cycle 
progression and the endoplasmic reticulum stress response. This result suggests the 
potential synergistic effects of the whole extract because of the presence of additional 
compounds at a lower concentration in combination with diterpenes, which deserves 
further attention. 
Therefore, the aims of our study were to perform a bioguided isolation of the bioactive 
fractions of rosemary extract by semi-preparative chromatography, to characterize them 
by high-performance liquid chromatography with electrospray ionization coupled to 
quadrupole-time-of-flight mass spectrometry (HPLC-ESI-QTOF-MS) and to study the 
comparative antiproliferative or cytotoxic activity of the whole extract and the fractions 
against several colon cancer cell lines to search for potential synergistic effects. 
MATERIAL AND METHODS 
2.1 Chemicals 
All chemicals were of analytical reagent grade and used as received. Formic acid and 
acetonitrile used for analytical and semi-preparative chromatography were purchased 
from Fluka, Sigma-Aldrich (Steinheim, Germany) and Fisher Scientific (Madrid, 
Spain), respectively. Water was purified by a Milli-Q system from Millipore (Bedford, 
MA, USA). Ursolic acid (UA), rosmarinic acid, genkwanin, diosmetin and luteolin were 
obtained from Extrasynthese (Genay, France). Carnosol (CAR), carnosic acid (CA) and 
apigenin were obtained from Fluka, Sigma-Aldrich (Steinheim, Germany). The stock 
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solutions containing these analytes were prepared in dimethyl sulfoxide (DMSO) and 
methanol (Fisher Scientific, Madrid, Spain) and stored at -80 °C until use. 
2.2 Rosemary-leaf extract 
The rosemary extract (RE) was obtained from dried rosemary leaves that were acquired 
from Herboristeria Murciana (Murcia, Spain) as described by Herrero et al. (Herrero et 
al., 2010). In brief, a supercritical fluid extraction system (Suprex Prep Master, Suprex 
Corporation, Pittsburg, PA, USA) was used, the flow of neat CO2 was set at 60 g/min, 
and the extraction conditions were 150 bar and 40 °C with 6.6% ethanol as a modifier. 
The extraction time was 5 hours to ensure high recovery efficiency. For solvent 
evaporation, a Rotavapor R-210 (Buchi Labortechnik AG, Flawil, Switzerland) was 
employed. 
2.3 The isolation and purification of rosemary compounds 
For the isolation of the rosemary compounds, the SFE extract obtained as described 
above was dissolved in DMSO up to a concentration of 50 mg/ml. Prior to injection, the 
extract solution was filtered with a single-use filter (0.45 μm). The fractionation of the 
rosemary-leaf extract was achieved by using a Gilson preparative HPLC system 
(Gilson, Middleton, USA) equipped with a binary pump (model 331/332), automated 
liquid handling solutions (model GX-271) and UV-Vis detector (model UV-Vis 156). 
The compounds were fractionated with an Ascentis C18 column (10 μm, 250 x 212 
mm) at room temperature. The mobile phases used for the separation consisted of water 
plus 0.1 % formic acid as eluent A, and acetonitrile as eluent B. The following multi-
step linear gradient was applied: 0 min, 5% B; 10 min, 45% B; 20 min, 55% B; 26 min, 
60% B; 46 min, 73% B; 50 min, 80% B; 55 min, 100% B; and 60 min, 5% B. The initial 
Page 6 of 32
  
7 
 
conditions were held for 15 min. The flow rate was 15 ml/min and the injection volume 
was 1 ml.  
The separated compounds were monitored by UV-Vis at a wavelength of 280 nm. The 
fraction collection step consisted of UV-based purification, and this step determined the 
elution time window for collecting each fraction. Finally, a total of 10 fractions were 
collected and the solvent was evaporated in darkness under a nitrogen stream. The 
residue of each fraction was weighed and stored at -80 °C until use. 
2.4 HPLC-ESI-QTOF-MS analysis 
The rosemary-leaf extract and the collected fractions obtained by semi-preparative 
chromatography were analyzed by HPLC-ESI-QTOF-MS. The extract was dissolved in 
ethanol at concentrations of 800 and 5000 µg/ml. The collected fractions were then 
dissolved in an appropriate volume of DMSO up to a concentration of 100 µg/ml. 
Finally, the solutions were passed through a 0.25 μm filter before HPLC analysis. The 
samples were analyzed by using an UPLC Acquity (Waters, Millford, MA, USA) 
coupled to a micrOTOF-Q II mass spectrometer (Bruker Daltonik, Bremen, Germany). 
The column was a Zorbax Eclipse Plus C18 (4.6 x 150 mm, 1.8 μm). The mobile phases 
consisted of water plus 0.1 % formic acid as eluent A and acetonitrile as eluent B. The 
separation was performed at room temperature with a gradient elution programmed at a 
flow rate of 0.8 ml/min. The multi-step linear gradient was as follows: 0 min, 5% B; 5 
min, 40 % B; 10 min, 60 % B; 30 min, 95% B; and 32.5 min, 5% B. The initial 
conditions were maintained for 5 minutes. The injection volume in the HPLC system 
was 5 μl.  
The UPLC system was coupled to the mass spectrometer via an ESI interface operating 
in negative ion mode with a capillary voltage of +4 kV. Because the flow rate under 
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chromatographic conditions was set at 0.8 ml/min to obtain a stable spray and 
consequently reproducible results, the effluent from the HPLC had to be split. A “T”-
type splitter was employed to reduce the flow from 0.8 to 0.2 ml/min. For all the 
experiments, detection was performed by considering a mass range of 50-1100 m/z, and 
by using nitrogen as nebulizing and drying gas. The optimum values of the ESI-QTOF 
parameters were as follows: drying gas temperature, 210 °C; drying gas flow, 9 l/min, 
nebulizing gas pressure, 2 bar; funnel 1 RF, 150.0 Vpp; funnel 2 RF, 200.0 Vpp; 
hexapole RF, 100.0 Vpp; transfer time, 70 μs; and pre-pulse storage, 7 μs. 
The instrument was calibrated externally with a 74900-00-05 Cole Palmer syringe pump 
(Vernon Hills, Illinois, USA) that was directly connected to the interface and contained 
a 10 mM sodium formate cluster solution. The calibration solution was prepared as 
follows: 10 μl of 1 M sodium hydroxide was mixed with 990 μl of 0.1 % formic acid in 
water:isopropanol (1:1, v/v). The mixture was injected at the beginning of each run and 
all the spectra were calibrated prior to compound identification. Due to the 
compensation of temperature drifts achieved inside the instrument, this external 
calibration provided accurate mass values that were better than 5 ppm. The accurate 
mass data of the molecular ions were processed with Data Analysis 4.0 software 
(Bruker Daltonik), which provides a list of possible elemental formulas via Generate 
Molecular Formula Editor. 
2.5 Cell lines and cultures 
Colon adenocarcinoma HT-29 and SW480 cells were obtained from the IMIM (Institut 
Municipal d´Investigació Médica, Barcelona, Spain) and ATCC (American Type 
Culture Collection, LGC Promochem, UK), respectively, and HGUE-C-1 was an 
established cell line derived from a primary colon cancer cell line from Hospital 
General Universitario de Elche. The cells were grown in DMEM supplemented with 5 
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% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 50 U/ml penicillin G, and 50 
µg/ml streptomycin at 37 °C in a humidified atmosphere with 5 % CO2. The cells were 
trypsinized every three days according to the manufacturer’s instructions, and they were 
seeded in 96-well plates. 
2.6 Antiproliferative activity assays 
To study the rosemary extract effect on the proliferation of HGUE-C-1, HT-29 and 
SW480 cell lines, the cells were seeded at a density of 5x103 cells/well, permitted to 
adhere overnight at 37 °C, and exposed to rosemary extract and the isolated fractions 
containing 30 or 60 µg/ml for 24 or 48 h. To obtain the concentration of rosemary 
extract that inhibited 50% of the cell growth (IC50 value), the cells were treated with 
various concentrations of extract (0-100 µg/ml), and cell proliferation was estimated by 
MTT assay. After incubations in the presence of the extract or the fractions for 24 or 48 
h, the cells were washed with PBS and incubated with MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5 diphenyltetrazolium bromide) for 3-4 h at 37 °C and 5% CO2. The medium was 
removed, and 100 µl of DMSO per well was added to dissolve the formazan crystals. 
The plates were shaken for 15 min and analyzed by using a microplate reader 
(SPECTROstar Omega, BMG LabTech GmbH, Offenburg, Germany) at 570 nm.  
2.7 Statistical analysis 
The values are represented as the means ± SD of 4-6 determinations, depending on the 
assay. The values were subjected to statistical analysis (one-way ANOVA to compare 
between different treatments, Student’s t-test for unpaired samples and Tukey’s test for 
multiple comparisons). Dose response curves and IC50 values were obtained by non-
linear regression analysis (sigmoidal dose responses with variable slopes) and compared 
by using two-way ANOVA with a Bonferroni post-test. The IC50 values are expressed 
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as the means of three experiments. All the calculations and adjustments were performed 
by using Graph Pad Prism version 5.01 software (Graph Pad Software Inc., CA, USA). 
 
RESULTS 
3.1 Quantitative characterization of the rosemary-leaf extract 
Figure 1 shows the base peak chromatogram (BPC) of the extract that was analyzed as 
described in the Material and Methods section in which the main peaks have been 
numbered according to their elution order. The rosemary-leaf extract under study was 
qualitatively characterized in a previous work (Borrás Linares et al., 2011); however, 
quantitative data were not reported. Table 1 summarizes the quantitative results 
obtained by HPLC-ESI-QTOF-MS for the major compounds in the extract. 
For quantitative purposes, standard calibration graphs of CAR, CA, UA, rosmarinic 
acid, genkwanin, diosmetin and apigenin were prepared by using luteolin at a 
concentration of 5 ppm as an internal standard. The validation of the proposed method 
was performed with linearity, sensitivity, and precision parameters. Table 2 shows the 
limits of detection (LODs) and quantification (LOQs), calibration range, calibration 
equations, and regression coefficient (r2) for all the standards used. All calibration 
curves showed good linearity between different concentrations depending on the 
analytes studied. The LODs and LOQs for individual compounds in standard solutions 
were also calculated as S/N = 3 and S/N = 10, respectively, where S/N is the signal-to-
noise ratio. The repeatability of the method was measured as the relative standard 
deviation (RSD %) in terms of concentration. The rosemary-leaf extract was injected 
several times (n = 6) on the same day (intraday precision) and 3 times on 2 consecutive 
days (interday precision, n=12). The intraday repeatability of the developed method for 
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all analytes ranged from 0.09 to 3.67 %, whereas the interday repeatability ranged from 
0.16 to 4.21 %. 
The compound concentrations were determined by using the corrected area for each 
individual compound (three replicates) and by interpolating in the corresponding 
calibration curve. Apigenin, diosmetin, genkwanin, CAR, CA and UA were quantified 
by using the calibration curves obtained from their respective commercial standards. 
The other compounds were tentatively quantified on the basis of calibration curves from 
other compounds with structural similarities. Rosmanol, its isomers epiisorosmanol and 
epirosmanol, miltipolone, rosmadial and rosmaridiphenol were quantified with CAR 
standard. Hinokione and 12-methoxycarnosic acid were expressed as CA. The UA was 
used to quantify augustic, benthamic, micromeric and betulinic acids, in addition to 
anemosapogenin. Finally, a genkwanin standard was used for cirsimaritin 
quantification. [9]-shogaol was expressed as rosmarinic acid, and diosmetin was used to 
estimate the hispidulin and cirsiliol contents. Despite the fact that the response of the 
standards may differ from those of the analytes, the concentration of each compound 
present in the whole extract was estimated (Table 1).  
3.2 Isolation and analysis of fractions from rosemary-leaf extract 
The major compounds present in the rosemary-leaf extract were isolated by semi-
preparative chromatography to study their individual anticancer activity. A total of 10 
fractions contained almost pure compounds were collected and selected for their 
bioactivity evaluation based on the UV chromatogram registered in the semi-preparative 
system, which corresponded to the major compounds of the extract. The composition of 
these fractions (Table 3) was analyzed and quantitated by HPLC-QTOF as previously 
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described. Except for fractions F4 (3 compounds), F9 (2 compounds) and F10 (2 
compounds), the purity of the fractions were of 72 % (w/w) and above. 
3.3 The effects of rosemary-leaf extract and isolated fractions on cell proliferation 
The antiproliferative/cytotoxic activity of the rosemary extract and the isolated fractions 
was assayed on HT-29, SW480 and HGUE-C-1 cell lines at 24 and 48 h. The incubation 
of the cells with rosemary extract yielded a dose-dependent decrease in cell viability for 
all colon cancer cell lines and treatment time lapse (Figure 2). The comparison of the 
IC50 values derived from Figure 2 is summarized in Figure 3. At 24 h, the HGUE-C-1 
cells were more sensitive to rosemary extract (IC50 = 12.7 µg/ml) than SW480 (IC50 = 
18.1 µg/ml) or HT29 cells (20.4 µg/ml). By contrast, the HGUE-C-1 and SW480 cells 
were almost equally sensitive after 48 h treatments (IC50 = 9.2 µg/ml and 8.1 µg/ml, 
respectively) and the HT29 cells were less sensitive (14.8 µg/ml). Significant 
differences between 24 and 48 h treatments were found in all cell lines (p<0.001), 
indicating that the longer the treatment the lower the IC50 values. The reduced IC50 
value after 48 hours of treatment was more dramatic for SW480 cells (Figs. 2 and 3). 
The capacity to reduce the cell proliferation of all the RE fractions was compared with 
that of the whole extract at two different concentrations (30 and 60 µg/ml) (Figure 4). 
The RE treatment exhibited the best results for all the tested conditions and cell lines or 
at least showed a similar level of inhibition to that of the most active fractions. In most 
cell lines, fractions 5, 7, 9 and 10 showed a similar level of antiproliferative activity 
than RE. However, fractions 2, 3, 4 and 6 exhibited less capacity to reduce cancer cell 
viability than RE. On the contrary, fractions 1 and 8 exhibited similar activity to that 
observed for RE in the HGUE-C-1 and SW480 cell lines, respectively. In general, most 
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fractions showed higher antiproliferative/cytotoxic activity in HGUE-C-1 relative to the 
other two cell lines. 
 
DISCUSSION 
Triterpenes were the most abundant compounds in RE (49.5% of the total identified 
compounds), followed by diterpenes (44.3%) and minor quantities of flavonoids (2.1%) 
(Figure 1). Diterpenes accounted for almost 11% of the total dry weight (dw) and 
triterpenes for approximately 12% dw (Table 1). Considering the individual 
compounds, the diterpene CA was the most abundant one (83 mg/g) followed by the 
triterpenes micromeric, betulinic and ursolic acids (47, 38 and 21.5 m/g, respectively), 
which were previously described in rosemary (Laszczyk, 2009). CAR, the δ-lactone 
derivative of CA, was also relevant (10 mg/g), and other diterpenes (rosmanol, 
rosmadial, and 12-methoxycarnosic acid), triterpenes (anemosapogenin, augustic acid, 
and benthamic acid), flavonoids (genkwanin) and [9]-shogaol were present at 
concentrations ranging from 1.36-10.1 mg/g extract. The rest of the compounds were all 
below 1 mg/g extract.   
The growth conditions (geographical and pedoclimatic factors), extraction and 
conservation procedures may significantly influence the phenolic composition of a 
botanical extract. Indeed, the phenolic diterpenes present in RE have been shown to be 
thermal and photo-degradable (Schwarz and Ternes, 1992). Solid-liquid extraction 
(SLE), pressurized-liquid extraction (PLE) and supercritical fluid extraction (SFE) have 
been used to extract phenolic compounds from rosemary. The studied rosemary-leaf 
extract exhibited a high CA content compared to the data previously reported in 
literature for PLE and SFE rosemary extracts (Herrero et al., 2010; Yesil-Celiktas et al., 
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2007). This result could be explained due to the use of ethanol as co-solvent in SFE 
performed in this research. Concerning the presence of intermediate phenolic diterpenes 
derived from CA, these compounds were found in lower amount compared to other 
extraction processes (Herrero et al., 2010; Kontogianni et al., 2013). This fact suggests a 
low degradation level for some compounds, especially for CA, during the extraction 
procedure used in this research. In addition, regarding the flavonoid content, this extract 
showed slightly lower concentrations in comparison to various rosemary extracts 
obtained with SLE (Kontogianni et al., 2013). 
All the compounds present in the RE were identified in the purified fractions, except 
notohamosin B and taxodione, which appeared as newly identified compounds in 
fractions F4 and F9, respectively, and were most likely present at a very low 
concentration in the extract. After fractionating the RE, fractions 1, 2, 3, 5, 6, 7 and 8 
(Table 3) were pure and only presented single compounds in each one, namely 
rosmanol, epiisorosmanol, genkwanin, CAR, rosmadial, CA and 12-methoxycarnosic 
acid, respectively. The phenolic diterpenes CAR, CA, rosmadial, rosmanol and its 
isomer epiisorosmanol, and the flavonoid genkwanin, have been previously described in 
this plant source (Pérez-Fons et al., 2010; Almela et al., 2006; Señorans et al., 2000; 
Chen et al., 2005; Chen et al., 2006). Unfortunately, it was not possible to purify the 
compounds miltipolone, notohamosin B and anemosapogenin to homogeneity, and they 
were found to be mixed into fraction number 4. Miltipolone is a diterpenoid tropolone 
that was first identified in Salvia miltiorrhiza (Regasini et al., 2008). Notohamosin B is 
a nortriterpenoid isolated from methanol extracts of Notochaete hamosa Benth. and it 
has been identified in rosemary extract (Borrás Linares et al., 2011; Fujita et al., 1988). 
In addition, anemosapogenin is a triterpene, which is also called 23-hydroxybetulinic 
acid, and it is isolated from the aerial parts of rosemary (Mahmoud et al., 2005). 
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Fractions 9 and 10 yielded 2 compounds each with taxodione and [9]-shogaol for the 
first fraction and hinokione and betulinic acid in the second. [9]-shogaol, hinokione and 
betulinic acid were previously identified in different rosemary-leaf extracts, whereas 
taxodione has been detected in the stems of this plant (Kontogianni et al., 2013; Bai et 
al., 2010; Nakasugi, 1996; El-Lakany, 2004).  
The antiproliferative or cytotoxic activity of different rosemary compounds and extracts 
on various cancer cell lines and in vivo models have been reported previously including 
leukemia, prostate, breast, skin and colon cancers (Johnson, 2011; Einbond et al., 2012; 
Kar et al., 2012; Yesil-Celiktas et al., 2010; NGO et al., 2011). A compositional 
analysis of all these extracts indicates that phenolic diterpenes are thought to be the 
most active compounds against cancer cell proliferation followed by triterpenoids, 
which have shown lower activity. Consistent with this finding, the above-mentioned 
studies postulate that CA may be the major contributor to the antiproliferative activity 
exhibited by rosemary extract. This finding is consistent with our results from fraction 
F7, which was almost composed of pure CA, and it was one of the most active in most 
cell lines at the lowest concentration assayed (i.e., 30 µg/ml). In addition, fractions F5 
(containing CAR), F9 (containing taxodione) and F10 (containing hinokione + betulinic 
acid) were almost as antiproliferative as the whole extract on most cell lines, which is 
consistent with the strongest activity of diterpenes. Nevertheless, the high percentage of 
betulinic acid in F10 (81.0%) indicates that triterpenes may also significantly contribute 
to decreased cancer cell viability. F8, which contained almost pure 12-methoxycarnosic 
acid, also presented stronger antiproliferative activity in SW480 cells, in comparison 
with the other two cell lines, and F1 (rosmanol) had a similar differential effect on 
HGUE-C-1 colon cancer cells. The antiproliferative activity of 12-methoxycarnosic acid 
has also been reported in hepatome cell lines (Peng et al., 2007). Depending on the cell 
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type, this preferential effect may indicate that further modifications of the 
pharmacophore nucleus of diterpenes would lead to the design of more selective drugs 
against different colon cancer cell phenotypes. In any case, due to the complexity of the 
terpenoid composition of the rosemary extract, the coexistence of antiproliferative and 
cytotoxic effects in colon cancer cells may take place. The nature of this effect may 
deserve further attention. 
Reported IC50 values for carnosic acid, betulinic acid and ursolic acid were 48.5, 32.7 
and 26 μM respectively after 24 h treatments of HT-29 colon cancer cells (Barni et al., 
2012; Ding et al., 2013; Shan et al., 2009), whereas ursolic acid IC50 value on SW480 
colon cancer cells after 48 h treatments was 23.9 μM (Wang et al., 2013). No values 
were found for other diterpenes or triterpenes from rosemary on colon cancer cells in 
the literature. In agreement to our results, the reported IC50 values would be slightly 
under the lowest concentration used in this study for pure fractions, i.e. 30 g/mL. The 
anticancer activity of rosemary compounds both in vitro and in animal models has been 
recently reviewed (NGO et al., 2011). Consistent with our results, CA and CAR are 
proposed as the most active constituents of rosemary leaves that are responsible for 
antiproliferative effects on colon cancer cells with the contribution of some triterpenes 
such as UA. Whereas most diterpenes such as CA and CAR seemed to display 
antiproliferative or cytostatic activity, other diterpenes such as rosmanol and the 
triterpene UA exhibited apoptotic effects. CAR and CA have been shown to target 
multiple pathways associated with inflammation and cancer, which include nuclear 
factor kappa B (NF-κB), apoptosis-related proteins, the phosphatidylinositol-3-kinase 
(PI3K)/Akt proliferation pathway, androgen and estrogen receptors and antiangiogenic 
activity (Johnson, 2011; López-Jiménez et al., 2013). Studies performed in other cancer 
cell models show that their mechanism of action is unlikely to be tissue-specific. In our 
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study, the F1 fraction that contained rosmanol (an oxidative degradation product 
derived from CA or CAR) was also very active in the HGUE-C-1 colon cancer cell line 
derived from the primary tumor, which may require further research in relation to the 
specific phenotype of this cell line. In any case, the low abundance of diterpenes in RE 
(11%) does not justify its strong antiproliferative activity in comparison with that of 
almost pure fractions containing diterpenes such as F1, F2, F5, F6, F7 or F8 (72-98%). 
Like other pentacyclic triterpenes, betulinic acid has been suggested as a promising 
anticancer lead compound with broad anticancer activity in a series of cancer cell lines. 
This compound has demonstrated antiangiogenic, apoptotic, and immunomodulatory 
effects in addition to differentiation-inducing effects, which are believed to be related to 
the lupane moiety (Laszczyk, 2009). Betulinic acid was fairly abundant in RE (3.8%) 
and was the primary compound in F10 (81%), one of the most active fractions 
especially in SW480 colon cancer cells. This fraction also contained minor quantities of 
the diterpene hinokione, which most likely derives from CAR degradation. However, 
the abundance of betulinic acid and that of other triterpenes (12%) in the extract is not 
in accordance with the strong antiproliferative activity of the whole extract. Fraction 9 
also exhibited strong activity and contained [9]-shogaol, a gingerol-like phenol, and the 
diterpene taxodione. Shogaol-related compounds have shown apoptotic capacity in 
human colon cancer cells and taxodione from Salvia species exhibited cytotoxicity in 
leukemia cancer cells (Fu et al., 2014; Tayarani-Najaran et al., 2013).  
As a general consideration, the results pointed out that the extract, which contained 
approximately 11% diterpenes and 12% triterpenes, exhibited higher 
antiproliferative/cytotoxic properties than any of the purified fractions, which contained 
almost pure compounds at percentages over 72% purity (dry weight). This finding may 
reveal potential synergistic behavior between the different compounds in the extract. 
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This polypharmacological behavior of the RE would also reduce the possible emergence 
of drug-resistant phenotypes. We propose that the antiproliferative/cytotoxic activity of 
RE may be based on the complementary concurrence of diterpenes and triterpenes. The 
identification of the specific combinations of diterpenes and triterpenes that exhibit 
maximum anticancer activity and the character of this effect (cytostatic, cytotoxic or 
both) will inevitably demand additional research. 
 
CONCLUSIONS 
 A bioactive rosemary-leaf extract obtained by SFE and bearing strong 
antiproliferative/cytotoxic capacity was first quantitatively characterized by HPLC-ESI-
QTOF-MS, and CA proved to be the most abundant compound, followed by the 
triterpenes micromeric, betulinic and ursolic acids. Bioguided fractionation by the 
semipreparative chromatography of the extract to obtain pure compounds showed that 
CA, CAR, 12-methoxycarnosic acid, taxodione, hinokione and betulinic acid were the 
putative candidates for the antiproliferative activity in a panel of human colon cancer 
cells including a cancer cell line derived from a primary tumor. Nevertheless, the 
comparative antiproliferative study of the fractions and the whole extract revealed the 
potential synergistic effect between several components in the extract. 
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FIGURE CAPTIONS 
Figure 1. A base peak chromatogram obtained by performing a UPLC-ESI-QTOF-MS 
analysis of the rosemary-leaf extract, in which the peaks are identified with numbers 
according to their elution order. The insert indicates the relative percentage of 
compounds in the extract as distributed by families. 
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Figure 2. The sigmoidal dose-response curves of cell viability for the following three 
different colon cancer cell lines: HGUE-C-1, HT-29 or SW480 (A, B and C) in the 
presence of the RE. The cells were treated with different concentrations (0-100 µg/ml) 
of RE for 24 or 48 h. After the treatments, cell viability was measured by MTT assay. 
The data are expressed as the means of 6 replicates ± SD. 
 
Figure 3. IC50 values derived from cell viability plots with treatments of three colon 
cancer cell lines in the presence of RE after 24 and 48 hours. Different letters above the 
bars indicate statistically significant differences (p<0.001) between samples after two-
way ANOVA analysis. 
 
Figure 4. The effects of RE and its isolated fractions on the cell viability of the three 
colon cancer cell lines HGUE-C-1, HT-29 or SW480. The cells were treated with 
different concentrations (30 or 60 µg/ml) for 24 or 48 h. After the treatment, cell 
viability was measured by MTT assay. The values are represented as the percentage of 
viable cells (100% viability corresponds to non-treated control cells). The data are 
expressed as the means of 4 replicates ± SD. ** (p<0.01) and *** (p<0.001) indicate 
statistically significant differences in comparison with control cells. 
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Table 1. The quantitative results for compounds identified in the RE (Value = X ± SD). 
 
Peak Rt (min) m/z 
experimental 
m/z 
calculated 
Error 
(ppm) mSigma 
Molecular 
Formula Analyte 
Concentration 
(mg/g) 
% dry 
weight 
(w/w) 
1 11.84 269.0461 269.0455 2.2 17.7 C 15 H 10 O 5 Apigenin 0.50 ± 0.02 0.05 
2 12.18 299.0565 299.0561 -1.2 36.8 C 16 H 12 O 6 Hispidulin 0.31 ± 0.01 0.03 
3 12.40 329.0665 329.0667 0.6 7.2 C 17 H 13 O 7 Cirsiliol 0.34 ± 0.01 0.03 
4 13.55 299.0553 299.0561 2.8 7.3 C 16 H 12 O 6 Diosmetin 0.62 ± 0.04 0.06 
5 13.83 313.0721 313.0718 0.9 8.5 C 17 H 14 O 6 Cirsimaritin 0.78 ± 0.07 0.08 
6 13.94 345.1714 345.1707 1.9 7.9 C 20 H 26 O 5 Rosmanol 4.4 ± 0.1 0.44 
7 14.43 345.1709 345.1707 0.5 7.6 C 20 H 26 O 5 Epiisorosmanol 0.80 ± 0.05 0.08 
8 15.01 345.1709 345.1707 0.5 7.6 C 20 H 26 O 5 Epirosmanol 0.38 ± 0.02 0.04 
9 15.16 283.0620 283.0612 2.7 15.7 C 16 H 12 O 5 Genkwanin 2.61 ± 0.05 0.26 
10 18.36 299.1652 299.1653 0.3 5.5 C 19 H 24 O 3 Miltipolone 0.32 ± 0.04 0.03 
11 19.18 329.1770 329.1758 3.5 1.0 C 20 H 26 O 4 Carnosol 10 ± 1 1.00 
12 20.35 343.1548 343.1551 0.9 12.1 C 20 H 24 O 5 Rosmadial 1.36 ± 0.06 0.14 
13 21.04 471.3471 471.348 1.9 24.8 C 30 H 48 O 4 Anemosapogenin 6.5 ± 0.5 0.65 
14 21.38 315.1960 315.1966 1.9 13.9 C 20 H 28 O 3 Rosmaridiphenol 0.25 ± 0.05 0.02 
15 21.91 471.3471 471.3480 1.8 34.4 C 30 H 48 O 4 Augustic acid 6.5 ± 0.5 0.65 
16 22.35 471.3474 471.3480 1.3 25.1 C 30 H 48 O 4 Benthamic acid 2.1 ± 0.2 0.21 
17 22.65 331.1935 331.1915 6.2 12.6 C 20 H 28 O 4 Carnosic acid 83 ± 4 8.30 
18 24.89 345.2083 345.2071 3.3 13.6 C 21 H 30 O 4 12-methoxycarnosic acid 7.20 ± 0.01 0.72 
19 27.11 317.2128 317.2122 1.7 27.7 C 20 H 30 O 3 [9]-Shogaol 10.1 ± 0.3 1.01 
20 28.04 453.3356 453.3374 4.0 10.5 C 30 H 46 O 3 Micromeric acid 47 ± 2 4.70 
21 28.40 299.2015 299.2017 0.4 2.3 C 20 H 28 O 2 Hinokione 0.95 ± 0.08 0.09 
22 29.19 455.3519 455.3531 2.5 18.6 C 30 H 48 O 3 Betulinic acid 38 ± 3 3.80 
23 30.20 455.3519 455.3531 2.5 18.6 C 30 H 48 O 3 Ursolic acid 21.5 ± 0.6 2.15 
 
      Flavonoids 5.16 0.52 
 
      Diterpenes 108.66 10.87 
 
      Triterpenes 121.6 12.16 
 
      Others 10.1 1.01 
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Table 2. Analytical parameters for the standards used for quantification purposes. 
 
Analyte LOD (μg/ml) 
LOQ 
(μg/ml) 
Calibration 
range (μg/ml) Calibration equations r
2
 
Carnosol 0.019 0.06 0.1 - 25 y = 84.476 x +0.3537 0.989 
Carnosic acid 0.018 0.06 0.5 - 70 y = 94.036 x + 0.0152 0.9907 
Ursolic acid 0.070 0.22 0.5 - 50 y = 106 x + 56483 0.9763 
Rosmarinic acid 0.035 0.09 0.5 – 15 y = 40352 x - 0.0142 0.9909 
Genkwanin 0.014 0.04 0.1 – 15 y = 147.37 x -0.0399 0.9803 
Diosmetin 0.028 0.09 0.1 – 5 y = 51.106 x – 0.0386 0.9906 
Apigenin 0.016 0.05 0.5 – 5 y = 62.358 x + 0.0308 0.9912 
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Table 3. The composition of the selected purified fractions used for the antiproliferative assays. 
 
 
Fraction 
number 
m/z 
experimental 
Molecular 
Formula 
Error 
(ppm) mSigma Proposed compound 
Purity 
(% dw) 
F 1 345.1715 C
 20 H 26 O 5 -2.2 12.1 Rosmanol 82.6 
F 2 345.1714 C 20 H 26 O 5 -1.7 5.6 Epiisorosmanol 83.6 
F 3 283.0616 C 16 H 12 O 5 -1.3 12.2 Genkwanin 99.3 
F 4 
299.1655 C 19 H 24 O 3 -0.7 21.7 Miltipolone 40.0 
457.3325 C 29 H 46 O 4 -0.4 20.9 Notohamosin B 30.1 
471.3483 C
 30 H 48 O 4 -0.7 31.8 Anemosapogenin 13.1 
F 5 329.1755 C 20 H 26 O 4 1.1 15.7 Carnosol 82.6 
F 6 343.1556 C 20 H 24 O 5 -1.6 7.8 Rosmadial 72.0 
F 7 331.1922 C 20 H 28 O 4 -2.1 25.8 Carnosic acid 98.7 
F 8 345.2070 C 21 H 30 O 4 0.2 6.6 12-methoxycarnosic acid 98.6 
F 9 313.1819 C 20 H 26 O 3 -3.0 7.5 Taxodione 44.0 317.2137 C 20 H 30 O 3 -4.6 19.3 [9]-Shogaol 50.0 
F 10 299.2021 C 20 H 28 O 2 -1.5 1.5 Hinokione 13.8 455.3518 C 30 H 48 O 3 2.8 1.1 Betulinic acid 81.0 
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